ISRCTN01591254
Unknown
N/A
Cluster randomised controlled trial of two Contingency Management schedules targeting treatment attendance or abstinence from street heroin use in people treated for heroin dependence
South London & Maudsley NHS Foundation Trust and Kings College London (UK)0 sites552 target enrollmentNovember 19, 2012
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Mental Health Research Network
- Sponsor
- South London & Maudsley NHS Foundation Trust and Kings College London (UK)
- Enrollment
- 552
- Last Updated
- 4 years ago
Overview
Brief Summary
2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29908336 protocol
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged \>18 years
- •2\. Seeking new episode of OST treatment
- •3\. Agree to 12 week treatment programme promoting abstinence
- •4\. Regular users of street heroin in preceding month (self report 15/30 use and all UDS in past 4 weeks opiate positive)
- •5\. Opiate dependent (meeting ICD\-10 criteria) and at liberty to participate in the study for 24 weeks
- •6\. Willing and able to provide informed consent
- •7\. Male or female
Exclusion Criteria
- •1\. Pregnant or breastfeeding
- •2\. Active mental health problem
- •3\. Patients referred into treatment under a criminal justice order
- •4\. Patients who cannot read English AND require the service of an interpreter to understand a brief oral description of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Speed of Increasing milk Feeds TrialISRCTN76463425niversity of Oxford (UK)2,804
Completed
N/A
Cardioprotection in CABG and AVR patients with RIPCISRCTN33084113Imperial College London (UK)120
Completed
N/A
Zoledronic acid in the management of malignant pleural mesotheliomaSpecialty: Respiratory disorders, Primary sub-specialty: Respiratory disordersUKCRC code/ Disease: Cancer/ Malignant neoplasms of respiratory and intrathoracic organsCancerMalignant neoplasms of respiratory and intrathoracic organsISRCTN45536692orth Bristol NHS Trust22
Completed
N/A
PD COMM StudyParkinson's diseaseNervous System DiseasesISRCTN12421382niversity of Birmingham388
Completed
Phase 2
BioBlock nasal spray against COVID-19ISRCTN48554326niversity of Tartu342